| Name | Title | Contact Details |
|---|
Skye Bioscience Inc. is a clinical-stage biotechnology company based in San Diego, California. The company focuses on developing innovative therapeutics for metabolic diseases, particularly obesity, by modulating the endocannabinoid system. Skye Bioscience is advancing its lead product, Nimacimab, a monoclonal antibody that targets peripheral CB1 receptors. This treatment aims to provide effective weight loss solutions while minimizing neuropsychiatric side effects associated with previous therapies. Nimacimab is currently in a Phase 2 trial, evaluating its efficacy in weight loss and metabolic health. The company is also exploring combination therapies to enhance treatment outcomes. Skye Bioscience positions Nimacimab as a potential alternative to existing GLP-1-based therapies, targeting patients who need sustainable weight loss with improved safety profiles. The obesity drug market presents significant opportunities, and Skye is actively participating in clinical trials and industry conferences to advance its mission in metabolic health.
Understanding Business is a Berkeley, CA-based company in the Business Services sector.
Btu/Data Transmission Network is a Red Bank, NJ-based company in the Business Services sector.
Superior Silica Sands is a leading manufacturer and distributor of quality Northern sand, and native Texas sand. The company has a diverse product line consisting of coarse sands used in fracturing, sport fields, water filtration, foundries, and constr...
Emsi is a labor market analytics firm. We collect and integrate complex labor market data and build user-friendly tools to help you understand employment, economic trends, and training needs for your region. We believe that a skilled, well-prepared workforce drives economic prosperity. We work with clients in higher education, workforce development, economic development, site selection, and talent acquisition.